- Home
- FENG vs GDTC Comparison
FENG vs GDTC Comparison
Compare FENG & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENG
- GDTC
- Stock Information
- Founded
- FENG 1998
- GDTC 2018
- Country
- FENG China
- GDTC Singapore
- Employees
- FENG N/A
- GDTC N/A
- Industry
- FENG Broadcasting
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- FENG Industrials
- GDTC Health Care
- Exchange
- FENG Nasdaq
- GDTC Nasdaq
- Market Cap
- FENG 25.2M
- GDTC 28.0M
- IPO Year
- FENG 2011
- GDTC 2023
- Fundamental
- Price
- FENG $2.32
- GDTC $2.02
- Analyst Decision
- FENG
- GDTC Buy
- Analyst Count
- FENG 0
- GDTC 1
- Target Price
- FENG N/A
- GDTC $5.00
- AVG Volume (30 Days)
- FENG 6.9K
- GDTC 8.9K
- Earning Date
- FENG 08-12-2025
- GDTC 01-01-0001
- Dividend Yield
- FENG N/A
- GDTC N/A
- EPS Growth
- FENG N/A
- GDTC N/A
- EPS
- FENG N/A
- GDTC N/A
- Revenue
- FENG $97,280,369.00
- GDTC $368,838.00
- Revenue This Year
- FENG N/A
- GDTC $5.37
- Revenue Next Year
- FENG N/A
- GDTC N/A
- P/E Ratio
- FENG N/A
- GDTC N/A
- Revenue Growth
- FENG 1.04
- GDTC N/A
- 52 Week Low
- FENG $1.28
- GDTC $1.20
- 52 Week High
- FENG $3.89
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- FENG 57.51
- GDTC 40.10
- Support Level
- FENG $2.22
- GDTC $2.01
- Resistance Level
- FENG $2.35
- GDTC $2.22
- Average True Range (ATR)
- FENG 0.12
- GDTC 0.09
- MACD
- FENG 0.01
- GDTC -0.02
- Stochastic Oscillator
- FENG 75.81
- GDTC 5.88
About FENG Phoenix New Media Limited
Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives revenue from China.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.